Regeneron Pharmaceuticals Regn Q3 2018 Results Earnings Call Transcript | Latest News RSS feed

Regeneron Pharmaceuticals Regn Q3 2018 Results Earnings Call Transcript - Latest News


Regeneron Pharmaceuticals (REGN) Q3 2018 Results - Earnings Call Transcript

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q3 2018 Earnings Call November 6, 2018 8:30 AM ET Executives Manisha A. Narasimhan - Regeneron Pharmaceuticals, Inc. Leonard S. Schleifer - Regeneron Phar... read more

Is Regeneron Pharmaceuticals the Best Biotech Stock to Buy?

A full transcript follows the video. 10 stocks we like better than Regeneron Pharmaceuticals ... hitting the market in, we'll call it 18 months. Harjes: Yeah, when you look at Regeneron's most recent ... read more

Regeneron Investors Cheer Q3 Earnings Beat, Eylea Growth

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) reported its third-quarter financial results before the markets opened on Friday. The company posted $3.13 in earnings per share (EPS) on $1.22 billion in ... read more

Looking for another news?


Regeneron (REGN) to Report Q3 Earnings: Is a Beat in Store?

Regeneron Pharmaceuticals, Inc. REGN is scheduled to release third-quarter 2018 results on Nov 6 ... particularly on Eylea and Dupixient’s uptake during the earnings call. Investors are also expected ... read more


Regeneron Pharmaceuticals Earnings Rise 29% In Q3

(RTTNews) - Regeneron Pharmaceuticals (REGN) revealed a profit for its third quarter ... Regeneron Pharmaceuticals earnings at a glance: -Earnings (Q3): $470.45 Mln. vs. $364.97 Mln. last year. -Earni... read more

Regeneron Pharmaceuticals Inc Average Basic Shares Outstanding (Quarterly)

Average Basic Shares Outstanding are the average number of current shares in company's stock outstanding over the reporting period, before accounting for the effects of dilution from events like exerc... read more

Regenerating Biotech Portfolios with Cell Therapies, Antibodies and Small Molecules

Reni Benjamin of Raymond James has watched biotechnology move into a new era in which cells and genes can be manipulated to produce true disease-modifying results ... where Regeneron Pharmaceuticals I... read more

Regeneron Pharmaceuticals Q3 adjusted earnings Beat Estimates

(RTTNews) - Regeneron Pharmaceuticals (REGN) announced earnings for its third quarter ... Regeneron Pharmaceuticals earnings at a glance: -Earnings (Q3): $675.49 Mln. vs. $470.46 Mln. last year. -EPS ... read more

Eli Lilly (LLY) to Report Q3 Earnings: What's in the Cards?

Eli Lilly and Company LLY will report third-quarter 2018 ... an earnings beat in their upcoming releases. Regeneron Pharmaceuticals, Inc. REGN has an Earnings ESP of +4.65% and a Zacks Rank #3. The co... read more

New Osteoarthritis Treatment Could Precipitate Another Blockbuster Drug

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) both saw handy gains on Thursday after the companies posted positive topline results from their late- ... read more

Regeneron Pharmaceuticals (REGN) Q3 2017 Results - Earnings Call Transcript

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q3 2017 Earnings ... on today's call. Information regarding our use of non-GAAP financial measures and a reconciliation of those measures to GAAP is avail... read more

Regeneron Pharmaceuticals Inc (REGN) Q3 2018 Earnings Conference Call Transcript

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q3 2018 Earnings ... discussed in today's call. Information regarding our use of non-GAAP financial measures and a reconciliation of those measures to GAAP ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us